Literature DB >> 3914638

Co-localization of neuropeptide tyrosine (NPY) and its C-terminal flanking peptide (C-PON).

S Gulbenkian, J Wharton, G W Hacker, I M Varndell, S R Bloom, J M Polak.   

Abstract

Neuropeptide tyrosine (NPY) is one of the most abundant and widespread peptides in the mammalian nervous system. Recent isolation and sequencing of the DNA encoding NPY has predicted the existence of a 97 amino acid precursor peptide. Proteolytic processing of this precursor could yield three separate peptide products, an N-terminal signal peptide, neuropeptide tyrosine and a 30 amino acid C-terminal flanking peptide (C-PON). Here, we present evidence that the predicted C-flanking peptide of NPY is widely distributed in both the central and peripheral nervous systems of several mammalian species including man, and has an identical distribution to NPY. It was also demonstrated, using correlative light microscopic immunostaining on serial sections and double electron microscopic immunocytochemistry, that C-PON and NPY immunoreactivities are co-localized in neuronal cell bodies of the brain cortex, sympathetic ganglion cells, norepinephrine-containing granules of the adrenal medulla and in human pheochromocytoma tumor cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3914638     DOI: 10.1016/0196-9781(85)90456-5

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  21 in total

1.  Neural elements in the normal and experimentally injured porcine intervertebral disk.

Authors:  E Kääpä; M Grönblad; S Holm; P Liesi; S Murtomäki; H Vanharanta
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

2.  Organization of the guinea-pig uterine innervation. Distribution of immunoreactivities for different neuronal markers. Effects of chemical- and pregnancy-induced sympathectomy.

Authors:  P Alm; L M Lundberg; J Wharton; J M Polak
Journal:  Histochem J       Date:  1988-05

3.  Increase in immunoreactivity for endothelin-1 in blood vessels of rat liver metastases: experimental sarcoma and carcinoma.

Authors:  A Loesch; M Turmaine; M Loizidou; R Crowe; S Ashraf; I Taylor; G Burnstock
Journal:  J Anat       Date:  1997-08       Impact factor: 2.610

4.  Immunohistochemical and ultrastructural localisation of peptide-containing nerves and myocardial cells in the human atrial appendage.

Authors:  J Wharton; S Gulbenkian; A Merighi; D M Kuhn; R Jahn; K M Taylor; J M Polak
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

Review 5.  Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis.

Authors:  Marco Marzioni; Giammarco Fava; Antonio Benedetti
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 6.  Heterogeneity of the intrahepatic biliary epithelium.

Authors:  Shannon Glaser; Heather Francis; Sharon Demorrow; Gene Lesage; Giammarco Fava; Marco Marzioni; Julie Venter; Gianfranco Alpini
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

7.  C-PON immunoreactive neurons in the neostriatum of the hedgehog (Erinaceus europaeus): a correlated light- and electron-microscopic study.

Authors:  R M Villalba; R Martínez-Murillo; J M Polak; J Rodrigo
Journal:  Cell Tissue Res       Date:  1994-07       Impact factor: 5.249

8.  Peptidergic nerves in human dental pulp. An immunocytochemical study.

Authors:  A Casasco; A Calligaro; M Casasco; D R Springall; J M Polak; P Poggi; C Marchetti
Journal:  Histochemistry       Date:  1990

9.  Effect of three animal models of inflammation on nerve fibres in the synovium.

Authors:  P I Mapp; D A Walsh; N E Garrett; B L Kidd; S C Cruwys; J M Polak; D R Blake
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

Review 10.  Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides.

Authors:  Marco Marzioni; Giammarco Fava; Domenico Alvaro; Gianfranco Alpini; Antonio Benedetti
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.